In part 2, Dr Mikhail Kosiborod and Dr Arun Sanyal dissect the results of a recent publication reporting the efficacy and safety of the GLP-1 RA semaglutide in a population of NASH patients.
Recorded remotely from Kansas City and Virginia, 2020.
Video
Published: 04 Mar 2021
Views:
376Likes:
3In part 2, Dr Mikhail Kosiborod and Dr Arun Sanyal dissect the results of a recent publication reporting the efficacy and safety of the GLP-1 RA semaglutide in a population of NASH patients.
Recorded remotely from Kansas City and Virginia, 2020.
This video was supported by an unrestricted educational grant from Novo Nordisk.